Tehila Feinberg, Michelle Rougerie, Yehuda S Dahan, Michael H Dahan
{"title":"非心血管并存疾病妇女使用激素避孕的综述全面审查。","authors":"Tehila Feinberg, Michelle Rougerie, Yehuda S Dahan, Michael H Dahan","doi":"10.23736/S0026-4784.20.04509-8","DOIUrl":null,"url":null,"abstract":"INTRODUCTION Previously, the American College of Obstetrics and Gynecology (ACOG) had published an excellent practice bulletin addressing the use of hormone contraception in women with pre-existing medical conditions. This practice bulletin became out of date. The Centers for Disease Control and prevention (CDC) of the United States subsequently developed a point form guideline for the use of oral contraceptives in women with co-existing medical conditions. EVIDENCE ACQUISITION Although this acts as a guide, it leaves the clinician without an understanding of why they are doing what they are doing. This article, is one of two related to women with co-existing medical conditions. EVIDENCE SYNTHESIS In this article we will provide an update of the scientific knowledge since the publication of the ACOG guideline (2006). It is to be used as a supplement for those who desire more information than is found in the CDC guidelines. CONCLUSIONS Although some recommendations have remained unchanged over the years, the development of lower dose contraceptive pills as well as the increased incidence of comorbid conditions, such as metabolic syndrome, in younger women seeking contraception has brought along new research and new evidence to guide clinicians in the prescription of these medications.","PeriodicalId":18745,"journal":{"name":"Minerva ginecologica","volume":"72 2","pages":"82-89"},"PeriodicalIF":1.0000,"publicationDate":"2020-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A review of the use of hormonal contraception in women with non-cardiovascular coexisting medical conditions. A comprehensive review.\",\"authors\":\"Tehila Feinberg, Michelle Rougerie, Yehuda S Dahan, Michael H Dahan\",\"doi\":\"10.23736/S0026-4784.20.04509-8\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"INTRODUCTION Previously, the American College of Obstetrics and Gynecology (ACOG) had published an excellent practice bulletin addressing the use of hormone contraception in women with pre-existing medical conditions. This practice bulletin became out of date. The Centers for Disease Control and prevention (CDC) of the United States subsequently developed a point form guideline for the use of oral contraceptives in women with co-existing medical conditions. EVIDENCE ACQUISITION Although this acts as a guide, it leaves the clinician without an understanding of why they are doing what they are doing. This article, is one of two related to women with co-existing medical conditions. EVIDENCE SYNTHESIS In this article we will provide an update of the scientific knowledge since the publication of the ACOG guideline (2006). It is to be used as a supplement for those who desire more information than is found in the CDC guidelines. CONCLUSIONS Although some recommendations have remained unchanged over the years, the development of lower dose contraceptive pills as well as the increased incidence of comorbid conditions, such as metabolic syndrome, in younger women seeking contraception has brought along new research and new evidence to guide clinicians in the prescription of these medications.\",\"PeriodicalId\":18745,\"journal\":{\"name\":\"Minerva ginecologica\",\"volume\":\"72 2\",\"pages\":\"82-89\"},\"PeriodicalIF\":1.0000,\"publicationDate\":\"2020-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Minerva ginecologica\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.23736/S0026-4784.20.04509-8\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2020/3/17 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Minerva ginecologica","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23736/S0026-4784.20.04509-8","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/3/17 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
A review of the use of hormonal contraception in women with non-cardiovascular coexisting medical conditions. A comprehensive review.
INTRODUCTION Previously, the American College of Obstetrics and Gynecology (ACOG) had published an excellent practice bulletin addressing the use of hormone contraception in women with pre-existing medical conditions. This practice bulletin became out of date. The Centers for Disease Control and prevention (CDC) of the United States subsequently developed a point form guideline for the use of oral contraceptives in women with co-existing medical conditions. EVIDENCE ACQUISITION Although this acts as a guide, it leaves the clinician without an understanding of why they are doing what they are doing. This article, is one of two related to women with co-existing medical conditions. EVIDENCE SYNTHESIS In this article we will provide an update of the scientific knowledge since the publication of the ACOG guideline (2006). It is to be used as a supplement for those who desire more information than is found in the CDC guidelines. CONCLUSIONS Although some recommendations have remained unchanged over the years, the development of lower dose contraceptive pills as well as the increased incidence of comorbid conditions, such as metabolic syndrome, in younger women seeking contraception has brought along new research and new evidence to guide clinicians in the prescription of these medications.
期刊介绍:
The journal Minerva Ginecologica publishes scientific papers on obstetrics and gynecology. Manuscripts may be submitted in the form of editorials, original articles, review articles, case reports, therapeutical notes, special articles and letters to the Editor. Manuscripts are expected to comply with the instructions to authors which conform to the Uniform Requirements for Manuscripts Submitted to Biomedical Editors by the International Committee of Medical Journal Editors (www.icmje.org). Articles not conforming to international standards will not be considered for acceptance.